Attached files
file | filename |
---|---|
EX-10.3 - FORM OF LOCK-UP AGREEMENT - UNITED STATES ANTIMONY CORP | uamy_ex10-3.htm |
EX-10.2 - PLACEMENT AGENCY AGREEMENT - UNITED STATES ANTIMONY CORP | uamy_ex10-2.htm |
EX-10.1 - SECURITIES PURCHASE AGREEMENT - UNITED STATES ANTIMONY CORP | uamy_ex10-1.htm |
EX-5.1 - OPINION OF STOEL RIVES LLP - UNITED STATES ANTIMONY CORP | uamy_ex5-1.htm |
EX-4.1 - FORM OF COMMON STOCK PURCHASE WARRANT - UNITED STATES ANTIMONY CORP | uamy_ex4-1.htm |
8-K - CURRENT REPORT - UNITED STATES ANTIMONY CORP | uamy_8k.htm |
Exhibit 99.1
United States Antimony Corporation Announces $10.7 Million
Registered Direct Offering
Thompson
Falls, Montana – February 1, 2021 – United States
Antimony Corporation (NYSE AMERICAN: UAMY), today announced that it
has entered into a securities purchase agreement with certain
institutional investors, providing for the purchase and sale of
15,300,000 shares of common stock at a price of $0.70 per share in
a registered direct offering, resulting in total gross proceeds of
approximately $10.7 million, before deducting the placement
agents’ fees and other estimated offering expenses. The
Company also agreed to issue to the investors unregistered warrants
to purchase up to 7,650,000 shares of common stock in a concurrent
private placement. The warrants have an exercise price of $0.85 per
share of common stock, will be exercisable six months from the date
of issuance and will expire five and one-half years following the
initial date of issuance.
Roth
Capital Partners is acting as the sole placement agent in this
offering.
The
registered direct offering and private placement are expected to
close on or about February 3, 2021, subject to customary closing
conditions.
A shelf
registration statement on Form S-3 (File No. 333-252193) relating
to the shares of common stock to be issued in the registered direct
offering was previously filed with the Securities and Exchange
Commission (the “SEC”) on January 19, 2021 and declared
effective by the SEC on January 27, 2021. Such shares are being
offered only by means of a prospectus. A prospectus supplement and
the accompanying prospectus relating to and describing the terms of
the registered direct offering will be filed with the SEC and will
be available on the SEC’s website at www.sec.gov. When
available, copies of the prospectus supplement and the accompanying
prospectus relating to the registered direct offering may also be
obtained by contacting Roth Capital Partners, LLC, 888 San Clemente
Drive, Newport Beach, California 92660, by calling (800) 678-9147
or by e-mail at rothecm@roth.com.
The
unregistered warrants described above were offered in a private
placement under Section 4(a)(2) of the Securities Act of 1933, as
amended (the “Act”), and Regulation D promulgated
thereunder and, along with the shares of common stock underlying
the warrants, have not been registered under the Act or applicable
state securities laws. Accordingly, the warrants and underlying
shares of common stock may not be offered or sold in the United
States except pursuant to an effective registration statement or an
applicable exemption from the registration requirements of the Act
and such applicable state securities laws.
This
press release does not constitute an offer to sell or the
solicitation of an offer to buy these securities, nor shall there
be any sale of these securities in any jurisdiction in which such
offer, solicitation or sale would be unlawful prior to the
registration or qualification under the securities laws of any such
jurisdiction.
About United States Antimony Corporation
US
Antimony is a growing, vertically-integrated natural resource
company that has production and diversified operations in precious
metals, zeolite and antimony.
Forward-Looking Statements
This
Press Release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section
21E of the Securities Exchange Act of 1934 that are based upon
current expectations or beliefs, as well as a number of assumptions
about future events, including matters related to the Company's
operations, pending contracts and future revenues, ability to
execute on its increased production and installation schedules for
planned capital expenditures and the size of forecasted deposits.
Although the Company believes that the expectations reflected in
the forward-looking statements and the assumptions upon which they
are based are reasonable, it can give no assurance that such
expectations and assumptions will prove to have been correct. The
reader is cautioned not to put undue reliance on these
forward-looking statements, as these statements are subject to
numerous factors and uncertainties. In addition, other factors that
could cause actual results to differ materially are discussed in
the Company's most recent filings, including Form 10-K with the
Securities and Exchange Commission.